Loading...
Loading...
By Amilcar Estrada - Tue, 03/05/2024 - 08:00
While academia offers opportunities, the private sector has emerged as the most fertile ground for STEM professionals, writes Almícar Estrada.
Featured content
Thu, 04/11/2024 - 10:30
Thinking about finance from the perspective of open data represents a unique opportunity to move into the future, writes Nick Grassi.
https://mexicobusiness.news/tag/ibm
More Tech
By Mauricio Torres Echenagucia - Wed, 01/10/2024 - 09:00
The AI+ era is the stage with AI at the center of business decision-making and at the core of tech considerations, writes Mauricio Torres Echenagucia.
By Tomás Lujambio - Thu, 12/07/2023 - 08:30
Tech companies and global research institutions established an AI Alliance to propel the development of open, secure, and responsible AI technologies.
By Tomás Lujambio - Wed, 11/22/2023 - 08:30
British Embassy in Mexico convened industry leaders to deliberate on cyber risks and propose solutions tailored to Mexico's cybersecurity landscape
By Tomás Lujambio - Wed, 11/01/2023 - 13:01
The International Counter Ransomware Initiative aims to eliminate ransomware payouts to disrupt cybercriminals main funding mechanism.
By Tomás Lujambio - Thu, 10/12/2023 - 10:11
Mexico lacks sufficient financial insights to fully capitalize on its nearshoring potential and Israel leverages AI to enhance its military power.
By Tomás Lujambio - Fri, 10/06/2023 - 12:45
AI chatbots reshape the way businesses interact with their customers, increasing engagement while maintaining effective and professional interactions.
By Mauricio Torres Echenagucia - Thu, 10/05/2023 - 12:00
AI has reached a tipping point and it is time to introduce its many possibilities into business operations, writes Mauricio Torres Echenagucia.
By Tomás Lujambio - Tue, 10/03/2023 - 12:50
Generative AI is changing the way data is analyzed, allowing businesses to generate intelligence almost effortlessly, says HCLTech's Pablo Gallegos.
By Sofía Garduño - Thu, 03/23/2023 - 16:44
IBM Quantum System One will help Cleveland Clinic’s researchers to accelerate the pace of drug development.
